Un- and dedifferentiated endometrial carcinoma A rare entity with a wide range of differential diagnosis

Hoehn AK, Brambs CE, Opitz S, Erber R, Hartmann A, Horn LC (2019)


Publication Type: Journal article

Publication year: 2019

Journal

DOI: 10.1007/s00292-019-00670-1

Abstract

Dedifferentiated endometrial carcinomas (ECs) are composed of undifferentiated EC and a FIGO grade 1 or 2 endometrioid carcinoma. The undifferentiated component represents a malignant epithelial neoplasm with no obvious differentiation and immunohistochemical loss of PAX8, E-cadherin and focal expression of EMA and/or CK18 and the predominant presence of nuclear staining for INI1 (SMARCB1) and BRG1 (SMARCA4). The main differential diagnoses include poorly differentiated endometrioid EC, neuroendocrine carcinoma, lymphoma, plasmocytoma, high-grade endometrial stromal sarcomas, undifferentiated uterine sarcomas (UUS), carcinosarcomas, and metastases to the endometrium. The histogenesis is not yet fully understood and molecular data are still limited. Some tumors represent a loss of MHL1 and PMS2 staining due to MLH1-promotor methylation. Rare cases are associated with Lynch syndrome or POLE mutation. The un- or dedifferentiated EC represents a high-grade endometrial carcinoma that requires extended surgery and indicates a poor prognosis. In cases with mismatch repair protein deficiency or POLE mutation, immuno-oncological treatment with checkpoint inhibitors are a therapeutic option.

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Hoehn, A.K., Brambs, C.E., Opitz, S., Erber, R., Hartmann, A., & Horn, L.-C. (2019). Un- and dedifferentiated endometrial carcinoma A rare entity with a wide range of differential diagnosis. Pathologe. https://doi.org/10.1007/s00292-019-00670-1

MLA:

Hoehn, A. K., et al. "Un- and dedifferentiated endometrial carcinoma A rare entity with a wide range of differential diagnosis." Pathologe (2019).

BibTeX: Download